Drugdu.com expert's response:

When many pharmaceutical and medical device enterprises start overseas promotion, they will encounter a common problem: there are dozens or even hundreds of products in the company's product catalog, but which ones should be prioritized for key promotion on B2B platforms?

Some enterprises are used to uploading all their existing products, believing that the more products they list, the higher the chance of being searched by overseas buyers. Others directly select several best-selling products in the domestic market, assuming that items performing well at home will surely meet demands in overseas markets.

Both ideas are reasonable to a certain extent, but more factors need to be taken into account in actual overseas procurement scenarios. Whether a product can attract buyers' attention is related not only to market demand, but also to the enterprise's supply capacity, product documentation, target market access status and peer competition.

A Large Product Line Does Not Mean Every Item Is Suitable for Priority Promotion

For enterprises with rich product portfolios, the first step is to distinguish between "products the company can supply" and "products suitable for prioritized overseas market development at the current stage".

For example, an API enterprise has hundreds of product varieties. Some of them are mature products under long-term and stable production, with complete quality documents and production records; others, although listed in the product catalog, are mainly sourced from external procurement, with unstable actual delivery cycles, quality standards and document support.

If products are uploaded merely by quantity, overseas buyers may inquire about varieties that the enterprise cannot supply stably for the time being. Even if inquiries are obtained, subsequent cooperation will easily get stuck due to issues such as prices, delivery lead times, quality documents or production sources.

Medical device enterprises face similar situations. Some products are the core models produced for years, with complete specifications, certifications and export documents; others are salable but not yet prepared for the registration or certification required by target markets. If both types of products are allocated with the same promotion resources, the procurement opportunities they generate will not be equal.

Therefore, when selecting key products, enterprises should first examine which items they can currently provide stably, and whether these products have the basic conditions to support overseas procurement.

Are Products Selling Well Domestically Definitely Needed by Overseas Buyers?

Domestic sales volume can reflect the product maturity of an enterprise, but it cannot directly represent overseas market demand.

Differences exist in the medical systems, procurement channels and regulatory requirements of different countries, and the procurement performance of the same product can vary greatly across markets.

For instance, a certain type of medical consumable maintains stable sales in domestic hospital channels, but when entering the European market, it may need to meet different requirements for product specifications, packaging languages, certifications and distributor channels. If the enterprise does not have the corresponding documents for the time being, it will be difficult to convert the product into immediate orders even with strong competitiveness.

The same logic applies to APIs and pharmaceutical excipients. Some varieties have large demand in the domestic market, but overseas buyers may require specific quality standards such as USP or EP, or support from GMP, DMF and other registration documents. If suppliers cannot meet the requirements of target customers, inquiries generated from promotion will be hard to convert.

Thus, when screening key products, it is necessary to consider both overseas demand and self-owned supply conditions. Enterprises can judge which products have actual procurement opportunities in target markets by combining platform search data, historical inquiries, feedback from overseas customers, exhibition communications and peer product layouts.

It is worth noting that high search volume does not necessarily mean strong procurement demand, and a large number of inquiries do not represent high transaction value. Some conventional medical consumables have high procurement frequency, but they also have a large number of suppliers and face fierce price competition; certain special APIs, pharmaceutical intermediates or pharmaceutical equipment may have low inquiry frequency, but a single project may involve large procurement amounts or long-term cooperation.

Enterprises do not have to blindly pursue popular products. Instead, they should look for varieties where market demand matches their own advantages.

The Completeness of Product Documentation Will Affect Promotion Performance

In pharmaceutical B2B procurement, after locating a product, buyers usually need to know specific specifications and supply conditions. If the product page only contains the name and a brief introduction, multiple rounds of communication will be required later to confirm basic information.

For APIs, intermediates and excipients, key information includes product name, CAS number, quality standard, purity or content, packaging, production capacity and available quality documents. For medical devices, buyers focus on models, dimensions, materials, functions, applicable scenarios, sterilization methods, packaging, relevant certifications and technical documents.

Some enterprises hope to prioritize promoting products with high market popularity, but these products currently only have simple parameters, with incomplete quality documents, images and export materials. In contrast, some mature products, although not ranking top in search popularity, are equipped with complete specification sheets, test reports, stable supply records and clear target customer groups.

In the initial stage of promotion, the latter type of products are more likely to enter specific procurement communications.

Of course, complete documentation does not necessarily mean the product is suitable for key promotion. If the overseas market demand is limited, or the enterprise lacks competitiveness in terms of price, delivery lead time and product performance, it may not bring ideal promotion results even with a well-organized product page.

The selection of key products requires a comprehensive judgment combining market demand, supply advantages and documentation completeness.

How to Arrange the First Batch of Key Promoted Products?

For enterprises that are new to overseas promotion or planning to adjust their product layout on B2B platforms, they can first select 3 to 5 key products from existing items, and then gradually expand the scope according to the enterprise scale and product characteristics.

The first category can be mature products under long-term and stable production by the enterprise, with complete quality documents and certain export experience. Such products can well reflect the main business direction of the enterprise, and make it easier to demonstrate supply capacity to overseas buyers.

The second category can be products with clear overseas procurement demands recently and the enterprise has competitive advantages. For example, if an enterprise finds through exhibition communications, historical inquiries or platform data that a certain product is frequently inquired by buyers from target markets, and it has certain advantages in price, quality, delivery lead time or document support, it is worth prioritizing promotion resources.

The third category can appropriately select products with development potential, including newly developed product lines, medical devices with technical features, or characteristic raw materials that are being expanded in overseas markets. However, for such products, the supply stability, target market access and documentation preparation should be evaluated in advance, and excessive promotion resources should not be invested when conditions are not mature.

Take a medical consumable enterprise with 80 products as an example. If its long-term exported items including disposable urinary catheters, medical dressings and suction connecting tubes have complete documents and existing overseas customer procurement records, the enterprise can first optimize the titles, specifications and details of these products. Other products can still be uploaded gradually, but there is no need to promote all 80 products with equal priority at the very beginning.

For enterprises focusing on peptides, APIs or intermediates, a similar approach is also applicable. They can first select key varieties with stable supply, clear document support and definite overseas procurement demands, and then build relatively complete display content around these products.

Overseas Promotion Also Needs to Adjust Product Directions Based on Actual Feedback

After key products are selected, the product layout should not remain unchanged for a long time.

For example, if a product gets little search exposure after going online, the enterprise can check whether the product title, keywords and category are accurate, and whether the English names, CAS numbers or professional terms are completely used.

If a product has a certain number of views but no inquiries for a long time, the enterprise needs to further verify whether the specifications and parameters, price competitiveness, relevant qualifications and enterprise information are clear enough. Buyers may have found the product, but fail to see clear cooperation advantages when comparing suppliers.

If a product receives many inquiries but never enters the stages of sample provision, document review or quotation confirmation, the enterprise needs to check whether the inquiries match its actual supply capacity. Possible issues include unavailable specifications required by buyers, insufficient registration documents for target markets, too high MOQ, or delivery lead times that cannot meet the procurement plan.

All these feedbacks can help enterprises re-judge which products are worth continuing to promote.

On professional pharmaceutical B2B platforms such as Drugdu.com, suppliers can gradually improve their overseas promotion directions through product displays, enterprise homepages and inquiry feedback. For newly settled enterprises, instead of focusing all energy on increasing product quantity, it is more advisable to prioritize optimizing the titles, keywords, detailed parameters, images and relevant qualification information of several core products, and then adjust the subsequent product layout based on actual exposure and procurement feedback.

A large number of main products is an advantage in supply scope, but overseas buyers usually search for items with specific procurement demands. They care more about whether they can find suppliers that meet their requirements for specifications, quality and delivery, and will not directly decide to cooperate just because an enterprise has uploaded more products.

For enterprises that are new to overseas promotion, it is usually more worthwhile to select several products with clear demands, supply advantages and relatively mature documentation first, present these products clearly, and then gradually expand the product line, than to upload a large number of products with incomplete information at one time.